Document:

Exhibit
10.1

 

Memorandum
regarding Share Exchange Agreement

 

Dated
as of July 15, 2021

 

THIS
MEMORANDUM regarding Share Exchange Agreement (this “MEMORANDUM”) is agreed by and among Information Services International-Dentsu
Ltd. (the “Investor”), Heartcore Co., Ltd. (the “Company”), Mr. Sumitaka Yamamoto (the “Management Controller”)
and Heartcore Enterprises Inc., a company established under the Delaware laws (“HUS”) with respect to the Share Exchange
Agreement (the “Agreement”) to be executed by HUS, the Company and certain shareholders of the Company. Unless otherwise
specified herein any terminologies and procedures under the Japanese laws shall be interpreted, where context requires, to mean the corresponding
terminologies and procedures under the Delaware laws.

 

Article
1 (Purpose)

 

The
purpose of this Memorandum is to establish and enhance long-term and stable cooperative relationships with important business partners
and to improve the competitiveness and profitability of the Investor, the Company and HUS.

 

Article
2 (Execution of the Agreement)

 

The
Investor shall sign or seal the Agreement and the other documents required to complete to the transactions set forth in the Agreement
by July 15, 2021 (the “Closing Date”) in accordance with Article 5 and other provisions in this Memorandum. The parties hereto
acknowledge that at the closing of the transactions set forth in the Agreement, Investor will transfer to HUS the shares of stock that
Investor holds in the Company in exchange for shares of common stock, par value $0.0001 per share, of HUS, which shares of common stock
of HUS are referred to as the “Shares”).

 

Article
3 [Intentionally Omitted]

 

Article
4 (Representations and Warranties by Management Controller)

 

4.1
The Management Controller represents and warrants as an important basis for the execution of this Memorandum that the following to
be true and correct:

 

	 	(1) 	The Management
    Controller has the necessary power and authority to enter into this Memorandum and the Agreement and perform its obligations, is
    not violating any agreement to which it is a party, and has undergone necessary procedures and is not violating any condition thereof,
    and has provided a certificate of seal impression to the Investor prior to the execution of this Memorandum.
	 	 	 
	 	(2) 	The Management Controller
    has not engaged in any act that conflicts with any applicable laws, ordinances, notices, rules, orders, local codes, guidelines and
    other regulations, including those of Japan, Delaware and the U.S. (collectively, “Laws”) and the certificate of incorporation
    or articles of incorporation of HUS and the Company.

 

    	1

    	 

    

 

	 	(3) 	There is currently
    no pending or threatened judicial or other legal proceedings or administrative, tax or other proceedings that would affect the credit
    status of the Management Controller.
	 	 	 
	 	(4) 	Neither the Management
    Controller nor any Special Interested Parties of the Management Controller is an anti-social force or their equivalent (hereinafter
    collectively referred to as “Anti-Social Force”), and neither the Management Controller nor any Special Interested Parties
    of the Management Controller cooperates in or participates in the maintenance or operation of Anti-Social Force through providing
    funds to Anti-Social Force, doing acts equivalent thereto, or engaging in business transactions. In this Memorandum, “Special
    Interested Parties” shall mean Officers (including Officers’ Shareholding Association), their spouses and relatives by
    blood within the second degree of kinship, companies in which the majority of the number of shares issued are held by such Officers,
    and related companies and their officers.
	 	 	 
	 	(5) 	The information on the
    career of the Management Controller disclosed by the Company or the Management Controller to the investor is true and accurate, and
    are not false or misleading in any material respect.
	 	 	 
	 	(6) 	The Management Controller
    is the representative director of the Company and CEO of HUS and shall not concurrently serve as an officer or employee of any other
    company, organization or organization, other than subsidiaries or affiliate of the Company or HUS.

 

4.2.
The representations and warranties made by the Management Controller in each item of the preceding paragraphs shall remain in force until
the termination of this Memorandum.

 

Article
5 (Preconditions for Execution)

 

The
Investor’s execution of the Agreement is subject to the satisfaction of all of the following conditions unless waived by the Investor
in writing:

 

	 	(1) 	The documents
    delivered and information provided by HUS, the Company and the Management Controller with respect to the representations and warranties
    set forth in Article 4 and in connection with the execution of this Memorandum are accurate and sufficient as of the Closing Date
    (as defined in the Agreement; hereinafter the same).
	 	 	 
	 	(2) 	On or after the execution
    of this Memorandum and before the Closing Date, there will be no event that would have a significant impact on the operations, financial
    position, operating results, credit status, etc. of HUS or the Company or the Management Controller.
	 	 	 
	 	(3) 	It is reasonably expected
    that an amendment to the original memorandum between the Company and the Investor, dated July 25, 2018, that is satisfactory for
    the Investor will be concluded between the Company and the Investor in writing by July 15, 2021.
	 	 	 
	 	(4) 	HUS and the Company has
    delivered the following documents to the Investor by the Closing Date.

 

	 	(i) 	Copies of the
    minutes of the Board of Directors and the minutes of the General Meeting of Shareholders of the Company that approved the execution
    of this Memorandum and any document of HUS that are equivalent to the above
	 	 	 
	 	(ii) 	Appropriate certificates,
    reports or other documents of HUS, the Company and the Management Controller that are reasonably requested by the Investor.

 

    	2

    	 

    

 

Article
6 [Intentionally Omitted]

 

Article
7 (Compliance)

 

7.1
HUS, the Company and the Management Controller shall undertake to comply with the Laws and
the Articles of Incorporation of HUS and the Company.

 

7.2
HUS, the Company and the Management Controller shall respectively undertake that it will have no relationship with the Anti-Social Force
in the future.

 

Article
8 [Intentionally Omitted]

 

Article
9 (Prior Notice and notification on Important Matters)

 

9.1
HUS and the Company shall give advance notice to the Investor when the corporate organization that makes such decisions makes a decision
on any of the following matters (including corresponding matters under the Delaware law) pertaining to HUS or the Company.

 

	 	(1) 	Changes to
    the certificate of incorporation or articles of incorporation (limited to the creation of class shares, changes in the features of
    common shares as class shares, establishment of or changes in share units, and other changes that may affect the position of common
    shareholders)
	 	 	 
	 	(2) 	Dissolution, a petition
    for commencement of bankruptcy proceedings, civil rehabilitation proceedings or corporate reorganization proceedings filed by HUS,
    the Company or its directors
	 	 	 
	 	(3) 	Approval of demand for
    sale of the shares by the Management Controller
	 	 	 
	 	(4)	Loans, capital investment
    or other investments
	 	 	 
	 	(5)	Issuance of new shares,
    stock options, convertible bonds or debentures
	 	 	 
	 	(6)	Capital reduction
	 	 	 
	 	(7)	Acquisition, disposition
    or cancellation of treasury shares, acquisition, disposition or cancellation of treasury stock acquisition rights, or redemption,
    purchase, cancellation or acquisition of options or other rights
	 	 	 
	 	(8) 	Stock split or reverse
    stock split
	 	 	 
	 	(9) 	Merger, company split,
    share exchange (kabushiki koukan), share transfer (kabushiki iten) or share delivery (kabushiki-koufu)
	 	 	 
	 	(10) 	Transfer, acquisition,
    suspension or abolition of all or a part of a business, consolidation of branch offices or commencement of new business
	 	 	 
	 	(11) 	Significant business alliances
    or their dissolution
	 	 	 
	 	(12)	Approval of transfer of
    shares of HUS or the Company (including sales by HUS of the Company’s shares)

 

    	3

    	 

    

 

	 	(13)	Acquisition
    or disposition of shares of any Related Party of HUS or the Company (“Related Party” shall mean the Related Party defined
    in Article 8, paragraph 17 of the Regulation on Terminology, Forms, and Preparation Methods of Financial Statements; hereafter the
    same)
	 	 	 
	 	(14) 	Appointment and dismissal
    of Representative Directors, Directors, Executive Officers, Statutory Auditors, Statutory Accounting Advisors, Managers and other
    important employees
	 	 	 
	 	(15) 	Any transaction between
    the Company and its director which requires approval by the board of directors under the Japanese Companies Act and any equivalent
    transaction between HUS and its director
	 	 	 
	 	(16) 	Execution or change of
    important contracts or other legally significant juridical acts
	 	 	 
	 	(17) 	Establishment of subsidiaries
    and affiliates
	 	 	 
	 	(14) 	Change of business plan

 

9.2
[Intentionally omitted]

 

9.3
To the extent not in conflict with the laws of the United States or the State of Delaware or the rules and regulations of any securities
exchange or securities market on which HUS’ securities are traded or listed for trading, the Management Controller shall notify
the Investor in advance when making a decision on the following matters pertaining to the Management Controller.

 

	 	(1) 	A petition
    for bankruptcy or commencement of civil rehabilitation proceedings filed by the Management Controller himself
	 	 	 
	 	(2) 	Transfer or acquisition
    of shares of the Company or its Related Parties
	 	 	 
	 	(3)	Loans, debt guarantees
    or collateral
	 	 	 
	 	(4) 	The filing of a law suit,
    settlement or conclusion of a suit not based on a judicial decision by the Management Controller pertaining to a claim on property
    rights
	 	 	 
	 	(5) 	Conclusion or change of
    important contracts or other important juridical acts
	 	 	 
	 	(6)	Offering of the Shares
    held by the Management Controller upon an IPO (as defined below).

 

Article
10 (Report on Important Matters)

 

10.1
To the extent not in conflict with the laws of the United States or the State of Delaware or the rules and regulations of any securities
exchange or securities market on which HUS’ securities are traded or listed for trading, and provided that legal counsel to HUS
does not advise HUS that any such notification is inadvisable due to such information being material non-public information or due to
such disclosure being a breach of the fiduciary duties of the officers or Directors of HUS, HUS or the Company shall, when it becomes
aware of the following matters pertaining to HUS or the Company (including corresponding matters under the Delaware law), and the occurrence
of other matters that are important in terms of its operations, financial position, operating results, credit status, etc., immediately
report to the Investor a summary of the matters that occurred in writing.

 

	 	(1) 	Damage arising
    from disasters or operations
	 	 	 
	 	(2) 	Filing of a law suit by
    a third party which may affect its financial condition, or becoming subject to a judgment, or any order or award equivalent thereto
    which may affect its financial condition.

 

    	4

    	 

    

 

	 	(3) 	Petition for
    an injunction of the business or a provisional disposition order equivalent thereto, or conclusion of legal proceedings not based
    on an order or a judgement by the court.
	 	 	 
	 	(4) 	Revocation of license,
    suspension of business or other equivalent dispositions by an administrative agency based on laws and regulations, or accusation
    by an administrative agency for violation of the Laws
	 	 	 
	 	(5) 	Merger or other reorganization
    involving HUS, the Company, or any of their Related Parties.
	 	 	 
	 	(6) 	Filing of a petition for
    commencement of bankruptcy proceedings, commencement of civil rehabilitation proceedings, commencement of corporate reorganization
    proceedings, commencement of special liquidation or enforcement of the corporate security interest by a third party, suspension of
    payments or dishonor of bills or checks with regard to the Company or HUS
	 	 	 
	 	(7) 	Commencement of bankruptcy
    proceedings, commencement of civil rehabilitation proceedings, commencement of corporate reorganization proceedings, commencement
    of special liquidation or petition for exercise of corporate security interest, suspension of payments or dishonor of bills or checks
    pertaining to HUS, the Company or any of its Related Parties
	 	 	 
	 	(8) 	Suspension of transactions
    with material customers, suppliers, distributors, agents, or other business partners
	 	 	 
	 	(9) 	Occurrence of risk of default
    by an obligor of HUS or the Company, or a principal obligor of a guarantee obligation of which HUS or the Company is a guarantor
	 	 	 
	 	(10) 	Cancellation of debts by
    creditors, reduction or extension of interest or assumption or repayment of debts by third parties.

 

10.2
To the extent permitted by applicable law, and provided that legal counsel to HUS does not advise HUS that any such notification is inadvisable
due to such information being material non-public information or due to such disclosure being a breach of the fiduciary duties of the
officers or Directors of HUS, if the Management Controller becomes aware of the occurrence of the following matters pertaining to the
Management Controller and other matters that are important in terms of credit status, etc., the Management Controller shall immediately
report in writing the summary of the matters that occurred to the investors.

 

	 	(1) 	Filing of a
    law suit by a third party which may affect the financial condition of the Management Controller, or becoming subject to a judgement
    or any order or award equivalent thereto which may affect the financial condition of the Management Controller.
	 	 	 
	 	(2) 	Petition for commencement
    of bankruptcy or civil rehabilitation proceedings, suspension of payment or dishonor of bill or check by a third party.

 

Article
11 [Intentionally omitted]

 

    	5

    	 

    

 

Article
12 (Purchase of Shares by Management Controller)

 

12.1
In any of the following cases, the Investor shall have the right to demand that Management Controller purchase all or part of the Shares
(including any other option rights to acquire the Shares) held by the Investor pursuant to the provisions of this Article. Provided,
however, that Management Controller may, with the prior written consent of such Investor, perform the purchase obligations set forth
in this Article by arranging for a third party to purchase the Shares.

 

	 	(1) 	HUS, the Company
    or the Management Controller breaches any of its obligations under this Memorandum and the breaching Party fails to remedy such breach
    within thirty (30) days after receipt of notice from the Investor seeking to remedy such breach.
	 	 	 
	 	(2) 	If the representations
    and warranties under Article 4 are not true or accurate.
	 	 	 
	 	(3) 	Cases where it is subsequently
    found that the preconditions for the execution under Article 5 have not been satisfied.

 

12.2
In the case where the Investor transfers the Shares to the Management Controller and / or a third party pursuant to Article 12.1, the
per share transfer price for the Shares shall be the purchase price paid by the Investor for the acquisition of shares of the Company,
subject to appropriate adjustments for stock splits, stock consolidations, and similar events involving the Shares. For the avoidance
of doubt, the aggregate purchase price paid by the Investor for the acquisition of shares of the Company was 50,040,000 yen for 278 shares
of the Company (180,000 yen per share).

 

12.3.
In the event that a request is made by Investor pursuant to Article 12.1, without requiring any further acceptance, Management Controller
who received the request and / or the third party designated by the Management Controller pursuant to Article 12.1 (hereinafter referred
to as the “Purchaser” in this Article 12.3 through Article 12.6) shall be deemed to have accepted the request, and shall
be obligated to purchase, in accordance with the provisions of this Article 12, the requested number of Shares from the Investor. The
Purchaser shall pay to the Investor the full price of the Shares pursuant to the Article 12.1 immediately after the request pursuant
to Article 12.1 has been made, and the following provisions shall apply after such payment.

 

	 	(1) 	In the event
    that the delivery of a certificate is required under the Laws for the transfer of the Shares, the Investor shall deliver to the Purchaser
    the certificate representing the Shares promptly after the receipt of the transfer price in full. The Purchaser shall promptly complete
    procedures required for the transfer of the Shares, including changing the name registered with the register of shareholders and
    other registers relating to the Shares.
	 	 	 
	 	(2) 	In the event that the delivery
    of a certificate is not required under the Laws for the transfer of the Shares, the transfer of the rights in and to the Shares shall
    become effective upon the completion of the payment of the full amount of the transfer price, and the Investor shall cooperate with
    the procedures required for the transfer of the Shares, including changing the name registered with the register of shareholders
    or other registers related to the Shares upon the request of the Purchaser.
	 	 	 
	 	(3) 	Even in cases where approval
    for transfer of the Shares is required, the presence or absence of such approval shall not affect the obligations set forth in the
    preceding paragraph of the Purchaser to the Investor. Any request for approval of transfer to HUS or the Company and any other procedures
    relating to such approval of transfer shall be executed by the Purchaser at its own expense and responsibility.

 

    	6

    	 

    

 

	 	(4) 	Prior to the
    completion of payment of the transfer price in full by the Purchaser pursuant to Article 12.3, the Investor may withdraw the demand
    under Article 12.1 by giving notice to the Management Controller, and if the Investor expresses its intention to withdraw, the purchase
    of the Shares set forth in Article 12.3 shall be cancelled without prejudice without the consent of the Purchaser. The Investor may
    make the demand pursuant to Article 12.1 again after such withdrawal.

 

12.4
In the event any withholding tax is imposed upon the transfer price of the Shares pursuant to this Article, the amount equivalent to
such withholding tax shall be borne by the Purchaser and the Purchaser shall pay to the Investor the entire amount of the transfer amount
set forth in Article 12.2 so that the amount the Investor receives after withholding shall be the transfer price set forth in Article
12. 2.

 

12.5
HUS shall carry out the procedures necessary for the transfer of the Shares under this Article, and the Management Controller shall cooperate
fully with such procedures of HUS.

 

Article
13 (Business Report Meeting)

 

HUS
and the Company shall hold regular business briefings at least once a quarter (briefings by HUS and the Company can be held at the same
time), and shall provide the Investor with reports on the business execution of HUS and the Company and monthly trial balances of HUS
and the Company (including balance sheets, profit and loss statements, and cash flow statements).

 

Article
14 [Intentionally omitted]

 

Article
15 (Transfer of the Shares, etc. by Management Controller)

 

The
Management Controller shall not transfer, pledge or otherwise dispose of the shares of HUS held by the Management Controller to third
parties including HUS without following the procedures provided for in Article 16.

 

Article
16 (Tag Along)

 

16.1
If the Management Controller wishes to transfer all or part of the shares of HUS held by the
Management Controller (hereinafter referred to as the “Shares Subject to Transfer” in this Article) to a third party (hereinafter
referred to as the “Other Party” in this Article), the Management Controller shall notify the Investor in writing containing
all of the matters set forth in each of the following items (hereinafter referred to as the “Explanation of the Transfer Conditions”
in this Article), at least forty (40) business days prior to the scheduled date of payment of the transfer price of such shares, after
sufficient prior consultation with the Investor:

 

	 	(i) 	the Shares
    Subject to Transfer are scheduled to be transferred, and the Other Party has a genuine intent to purchase the Shares Subject to Transfer;
	 	 	 
	 	(ii) 	the total number of Shares
    Subject to Transfer to be transferred;
	 	 	 
	 	(iii) 	the transfer price per
    share;
	 	 	 
	 	(iv) 	the name and address of
    the Other Party;
	 	 	 
	 	(v) 	the scheduled payment date
    and method; and
	 	 	 
	 	(vi) 	other material terms for
    the transfer.

 

    	7

    	 

    

 

16.2
In the case referred to in Article 16.1, the Investor may request the Management Controller that the Investor will participate in the
transfer under the same terms and conditions as those stated in the Explanation of the Transfer Conditions and to transfer all of the
Shares held by the Investor to the Other Party to the transfer (hereinafter referred to as the “Request for Participation in Transfer”).
The Investor making a Request for Participation in Transfer shall submit a notice (hereinafter referred to as the “Notice of Desire
to Co-Sell”) within thirty (30) days after receipt of the notice set forth in Article 16.1 to the Management Controller, stating
that the Investor wishes to transfer the Shares to the Other Party.

 

16.3
The Management Controller shall not consummate such transfer until the period set forth in Article 16.2 has elapsed. In addition, if
the Request for Transfer in Participation is made, the Management Controller shall promptly negotiate with the Other Party and take all
necessary measures to transfer the Shares that the Investor desires to transfer in accordance with the Request for Participation in Transfer.
If the Investor delivers a Notice of Desire to Co-Sell, the Management Controller shall not sell any Shares Subject to Transfer until
a sale and purchase agreement is executed between the Investor and the Other Party under terms and conditions not less favorable than
those stated in the Explanation of the Transfer Conditions.

 

16.4
HUS and the Management Controller shall promptly obtain the approval of the Board of Directors, the General Meeting of Shareholders or
any other decision making body for the transfer of shares under this Article 16, if necessary, and shall take necessary measures relating
to such transfer, including the entry of items to be entered in the register of shareholders, and the Investor shall provide reasonably
necessary cooperation.

 

16.5
This Article 16 shall not apply to the offering of the shares of HUS made in the course of the contemplated IPO.

 

Article
17 (Damages, etc.)

 

17.1
HUS, the Company and the Management Controller shall be jointly and severally liable for any damages incurred by the Investor as a result
of a breach of their obligations under this Memorandum (including breach of representations and warranties under Article 4). The damages
in this paragraph shall include damages, losses and expenses (including reasonable attorneys’ fees).

 

172
Any information learned by the Investor through due diligence or other means undertaken in connection with the execution and performance
of this Memorandum shall have no effect on the validity, effectiveness, etc. of any representations and warranties made hereunder and
any compensation or remedy therefor.

 

17.3
The Management Controller shall not exercise any right to reimbursement against HUS and the Company acquired by the Management Controller
as a result of the performance of his joint and several liability under this Article without the prior written consent of the Investor
while the Investor is a shareholder of HUS.

 

    	8

    	 

    

 

Article
18 (Voluntary Resignation and Expiration of Term of Directors)

 

In
the event that the Management Controller voluntary resigns from the Representative Director of HUS or the Company or its term of office
expires, HUS or the Company shall immediately add another person who shall be concurrently responsible for the obligations incurred by
the Management Controller in connection with this Memorandum upon approval of the Investor.

 

Article
19 (Confidentiality Obligation)

 

19.1
Other than in connection with the IPO or as required by applicable law, the parties hereto shall not divulge the contents of this Memorandum
to any third party except with the consent of all other parties.

 

19.2.
The Investor shall not divulge to any third party, without the consent of HUS or the Company, any information HUS or the Company provided
to the Investor as confidential in writing (hereinafter referred to as “Confidential Information”) under this Memorandum.
However, the following information shall not be Confidential Information.

 

	 	(1)	Information known or publicly available at the time of disclosure
by HUS or the Company.
	 	 	 
	 	(2)	Information already held by Investor at the time of disclosure
by HUS or the Company.
	 	 	 
	 	(3)	Information disclosed after disclosure by HUS or the Company
or information that has become publicly known without being attributable to the Investor.
	 	 	 
	 	(4)	Information appropriately obtained from a third party with
legitimate authority.
	 	 	 
	 	(5)	Information required to be disclosed by public institutions,
etc. pursuant to the Laws.

 

19.3
Notwithstanding the preceding paragraph, the Investor may disclose the Confidential Information only to the officers and employees of
the Investor, attorneys, certified public accountants and tax accountants of the Investor, the Specified Related Parties (as defined
in the Financial Instruments and Exchange Act of Japan and other related laws and regulations, etc.) of the Investor, and the intended
recipient or transferee of the Shares held by the Investor, and shall have such recipients of Confidential Information comply with the
obligations equivalent to this Article 19.

 

19.4
The confidentiality obligations set forth in Article 19.1 through Article 19.3 above shall remain in force for a period of one (1) year
from the termination of this Memorandum in the event of termination pursuant to Article 22, Paragraph 1, Item 1, item 3 or item 4 and
shall expire upon such termination in the event of termination pursuant to Paragraph1, Item 2.

 

19.5
The provisions in this Article do not apply to disclosures to the lead managing underwriter of HUS in connection with the IPO (as defined
below).

 

Article
20 (Publication)

 

With
respect to any public announcement regarding this Memorandum, the nature of the announcement, the timing of the announcement and the
method of the announcement shall be made as agreed upon through consultation between the parties hereto. Provided, however, that this
shall not apply to cases where publication is obligatory based on applicable laws and regulations, etc. or the rules of a stock exchange.

 

    	9

    	 

    

 

Article
21. (Assignment of Contract)

 

The
parties hereto shall not assign or transfer to any third party any and all rights and obligations of the parties hereto arising under
or in connection with their positions hereunder.

 

Article
22. (Termination)

 

22.1
This Memorandum shall terminate:

 

	 	(1)	if the parties hereto unanimously agree to terminate this Memorandum;
	 	 	 
	 	(2)	if the Investor ceases to be a shareholder of HUS;
	 	 	 
	 	(3)	if an application by HUS to NASDAQ Capital Market for the listing
of its shares is approved by NASDAQ; or
	 	 	 
	 	(4)	upon the effectiveness of a registration statement filed by
HUS under the Securities Act of 1933, as amended, for an initial public offering of its stock (the “IPO”).

 

22.2.
Termination of this Memorandum shall be effective only for the future and, except as otherwise provided herein, any rights and obligations
arising under this Memorandum prior to such termination shall not be affected by such termination.

 

22.3
The Investor, the Company and the Management Controller confirms that (i) the Investment Agreement dated July 25, 2018, entered into
among the Investor, the Company and the Management Controller (the “Investment Agreement”), shall terminate among the Investor,
the Company and the Management Controller upon the Investor’s acquisition of the Shares pursuant to the Agreement, and (ii) the
Investment Agreement shall only henceforth terminate and the rights and the obligations which arose pursuant to the Investment Agreement
before the termination shall not be affected by the termination, unless otherwise specified in the Investment Agreement.

 

Article
23 (Burden of Costs)

 

23.1
Except for taxes on the income of Investor, HUS shall bear and pay all stamp taxes and other taxes and public charges payable in connection
with the execution of this Memorandum.

 

23.2
Except as otherwise provided in the preceding paragraph and elsewhere in this Memorandum, the parties hereto shall each bear all costs
and expenses incurred by them in connection with the negotiation, execution, execution and performance of their obligations under this
Memorandum. Provided, however, that this shall not apply to expenses incurred in seeking compensation for default or damage caused by
a breach of this Memorandum.

 

Article
24 (Governing Law)

 

This
Memorandum and all rights and obligations of the parties hereto arising under or in connection with this Memorandum shall be governed
by and construed in accordance with the laws of Japan.

 

Article
25 (Arbitration)

 

Any
dispute, controversy or claim arising from or in connection with this Memorandum shall be finally settled under the Commercial Arbitration
Rules of the Japan Commercial Arbitration Association. The place of arbitration shall be Tokyo, Japan.

 

Article
26 (Sincere Consultation)

 

Matters
not stipulated in this Memorandum shall be amicably resolved through mutual consultation between the parties in good faith.

 

Article
27

 

27.1
This Memorandum shall be prepared by counterparts and all the counterparts shall be deemed to constitute one original.

 

27.2
PDF version of the original signed page and sending the same by electronic means shall be deemed as exchange of original signed page.

 

[Signatures
appear on following page]

 

    	10

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed in two (2) copies and have hereunto affixed their names
and seals, each party retaining one (1) copy.

 

	Information
    Services International-Dentsu Ltd.	 
	 	 	 
	By:	/s/
    Shinichi Ogane	 
	Name:	Shinichi
    Ogane	 
	Title:	Senior
    Managing Director	 
	 	 	 
	Heartcore
    Co., Ltd.	 
	 	 	 
	By:	/s/
    Sumitaka Yamamoto	 
	Name:	Sumitaka
    Yamamoto	 
	Title:	CEO
    and President	 
	 	 	 
	Mr.
    Sumitaka Yamamoto	 
	 	 	 
	By:	/s/
    Sumitaka Yamamoto	 
	Name:	Sumitaka
    Yamamoto	 
	 	 	 
	Heartcore
    Enterprises Inc.	 
	 	 	 
	By:	/s/
    Sumitaka Yamamoto	 
	Name:	Sumitaka
    Yamamoto	 
	Title:	Chief
    Executive Officer	 

 

    	11Exhibit
10.2

 

 

 

Share
Exchange Agreement

 

by
and among

 

HeartCore
Enterprises, Inc.;

 

All
of the Shareholders of Heartcore Inc.;

 

And

 

Sumitaka
Yamamoto as the Shareholders’ Representative.

 

 

 

    	 

    	 

    

 

TABLE
OF CONTENTS

 

	 	 	 	 	PAGE
	 	 	 	 	 
	Article
    I.	 	DEFINITIONS	1
	 	Section
    1.01	 	Definitions.	1
	 	Section
    1.02	 	Interpretive
    Provisions.	4
	 	 	 	 	 
	Article
    II.	 	SHARE
    EXCHANGE	4
	 	Section
    2.01	 	The
    Exchange.	4
	 	Section
    2.02	 	Closing.	4
	 	Section
    2.03	 	Issuance.	5
	 	Section
    2.04	 	HeartCore
    Shareholders’ Deliverables at the Closing.	5
	 	Section
    2.05	 	Company
    Actions at the Closing.	5
	 	Section
    2.06	 	Tax
    Consequences.	5
	 	Section
    2.07	 	Additional
    Documents.	5
	 	 	 	 	 
	Article
    III.	 	REPRESENTATIONS
    AND WARRANTIES OF THE HEARTCORE SHAREHOLDERS	5
	 	Section
    3.01	 	Existence
    and Power.	5
	 	Section
    3.02	 	Due
    Authorization.	6
	 	Section
    3.03	 	Valid
    Obligation	6
	 	Section
    3.04	 	Governmental
    Authorization.	6
	 	Section
    3.05	 	Title
    to HeartCore Shares.	6
	 	Section
    3.06	 	No
    Conflict With Other Instruments	6
	 	Section
    3.07	 	Investment
    Representations	6
	 	 	 	 	 
	Article
    IV.	 	REPRESENTATIONS
    AND WARRANTIES OF THE COMPANY	9
	 	Section
    4.01	 	Corporate
    Existence and Power	9
	 	Section
    4.02	 	Due
    Authorization.	9
	 	Section
    4.03	 	Valid
    Obligation	9
	 	Section
    4.04	 	Governmental
    Authorization.	9
	 	Section
    4.05	 	No
    Conflict With Other Instruments	9
	 	Section
    4.06	 	Approval
    of Agreement	9
	 	 	 	 	 
	Article
    V.	 	INDEMNIFICATION	9
	 	Section
    5.01	 	Indemnification
    of Company.	9
	 	Section
    5.02	 	Indemnification
    of the HeartCore Shareholders.	10
	 	Section
    5.03	 	Procedure.	10
	 	Section
    5.04	 	Periodic
    Payments.	11
	 	Section
    5.05	 	Insurance.	12
	 	Section
    5.06	 	Limitations.	12
	 	Section
    5.07	 	Exclusive
    Remedy.	12
	 	 	 	 	 
	Article
    VI.	 	MISCELLANEOUS	13
	 	Section
    6.01	 	Governing
    Law	13
	 	Section
    6.02	 	Waiver
    of Jury Trial.	13
	 	Section
    6.03	 	Limitation
    on Damages.	13
	 	Section
    6.04	 	Brokers	13
	 	Section
    6.05	 	Notices	14
	 	Section
    6.06	 	Attorneys’
    Fees	14
	 	Section
    6.07	 	Confidentiality	14

 

    	i

    	 

    

 

	 	Section
    6.08	 	Third
    Party Beneficiaries	14
	 	Section
    6.09	 	Expenses	15
	 	Section
    6.10	 	Entire
    Agreement	15
	 	Section
    6.11	 	Survival	15
	 	Section
    6.12	 	Amendment;
    Waiver	15
	 	Section
    6.13	 	HeartCore
    Shareholders’ Representative.	16
	 	Section
    6.14	 	Arm’s
    Length Bargaining; No Presumption Against Drafter.	16
	 	Section
    6.15	 	Headings.	16
	 	Section
    6.16	 	No
    Assignment or Delegation.	16
	 	Section
    6.17	 	Commercially
    Reasonable Efforts	17
	 	Section
    6.18	 	Further
    Assurances.	17
	 	Section
    6.19	 	Specific
    Performance.	17
	 	Section
    6.20	 	Counsel.	17
	 	Section
    6.21	 	Counterparts	17

 

	Exhibit
    A 	HeartCore
    Shareholders’ HeartCore Shares and Shares of Company Stock to be Issued

 

    	ii

    	 

    

 

SHARE
EXCHANGE AGREEMENT

 

Dated
as of July 16, 2021

 

This
Share Exchange Agreement (this “Agreement”) is entered into as of the date first set forth above (the “Closing Date”)
by and between (i) HeartCore Enterprises, Inc., a Delaware corporation (the “Company”); (ii) the shareholders of HeartCore
Inc., a Japanese corporation (“HeartCore”) as set forth on the signature pages hereto (the “HeartCore Shareholders”)
and (ii) Sumitaka Yamamoto as the representative of the HeartCore Shareholders (the “Shareholders’ Representative”).
Each of the Company, each HeartCore Shareholder and the Shareholders’ Representative may be referred to herein collectively as
the “Parties” and separately as a “Party.”

 

WHEREAS,
the Company agrees to acquire from the HeartCore Shareholders all of the shares of stock of HeartCore held by the HeartCore Shareholders
in exchange for the issuance by the Company to HeartCore Shareholders of shares of the Company’s common stock, par value $0.0001
per share (the “Company Common Stock”); and

 

NOW
THEREFORE, on the stated premises and for and in consideration of the mutual covenants and agreements hereinafter set forth and the mutual
benefits to the Parties to be derived herefrom, and intending to be legally bound hereby, it is hereby agreed as follows:

 

Article
I. DEFINITIONS

 

Section
1.01 Definitions. The following terms, as used herein, have the following meanings

 

	 	(a)	“Action”
    means any legal action, suit, claim, investigation, hearing or proceeding, including any audit, claim or assessment for Taxes or
    otherwise.
	 	 	 
	 	(b)	“Affiliate”
    means, with respect to any Person, any other Person directly or indirectly Controlling, Controlled by, or under common Control with
    such Person.
	 	 	 
	 	(c)	“Agreement”
    has the meaning set forth in the introductory paragraph hereto.
	 	 	 
	 	(d)	“Authority”
    means any governmental, regulatory or administrative body, agency or authority, any court or judicial authority, any arbitrator,
    or any public, private or industry regulatory authority, whether international, national, Federal, state, or local.
	 	 	 
	 	(e)	“Business
    Day” means any day that is not a Saturday, Sunday or other day on which banking institutions in Delaware are authorized or
    required by law or executive order to close.
	 	 	 
	 	(f)	“Certificate”
    means the Certificate of Incorporation of the Company as in effect from time to time.
	 	 	 
	 	(g)	“Closing
    Date” has the meaning set forth in the introductory paragraph hereto.
	 	 	 
	 	(h)	“Closing”
    has the meaning set forth in Section 2.02.
	 	 	 
	 	(i)	“Companies
    Act” means the Japanese Companies Act.

 

    	 1

     

    

 

	 	(j)	“Company
    Common Stock” has the meaning set forth in the recitals hereto.
	 	 	 
	 	(k)	“Company
    Indemnified Party” has the meaning set forth in Section 5.01.
	 	 	 
	 	(l)	“Company
    Organizational Documents” means the Certificate and the Bylaws of the Company.
	 	 	 
	 	(m)	“Company”
    has the meaning set forth in the introductory paragraph hereto.
	 	 	 
	 	(n)	“Control”
    of a Person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies
    of such Person, whether through the ownership of voting securities, by contract, or otherwise. “Controlled”, “Controlling”
    and “under common Control with” have correlative meanings. Without limiting the foregoing a Person (the “Controlled
    Person”) shall be deemed Controlled by (a) any other Person (the “10% Owner”) (i) owning beneficially, as meant
    in Rule 13d-3 under the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, securities
    entitling such Person to cast 10% or more of the votes for election of directors or equivalent governing authority of the Controlled
    Person or (ii) entitled to be allocated or receive 10% or more of the profits, losses, or distributions of the Controlled Person;
    (b) an officer, director, general partner, partner (other than a limited partner), manager, or member (other than a member having
    no management authority that is not a 10% Owner ) of the Controlled Person; or (c) a spouse, parent, lineal descendant, sibling,
    aunt, uncle, niece, nephew, mother-in-law, father-in-law, sister-in-law, or brother-in-law of an Affiliate of the Controlled Person
    or a trust for the benefit of an Affiliate of the Controlled Person or of which an Affiliate of the Controlled Person is a trustee.
	 	 	 
	 	(o)	“Counsel”
    has the meaning set forth in Section 6.20.
	 	 	 
	 	(p)	“Direct
    Claim” has the meaning set forth in Section 5.03(c).
	 	 	 
	 	(q)	“Exchange
    Shares” has the meaning set forth in Section 2.03.
	 	 	 
	 	(r)	“Exchange”
    has the meaning set forth in Section 2.01(b).
	 	 	 
	 	(s)	“HeartCore
    Indemnified Party” has the meaning set forth in Section 5.02.
	 	 	 
	 	(t)	“HeartCore
    Shareholders” has the meaning set forth in the introductory paragraph hereto.
	 	 	 
	 	(u)	“HeartCore
    Shares” has the meaning set forth in Section 2.01(a).
	 	 	 
	 	(v)	“HeartCore”
    has the meaning set forth in the introductory paragraph hereto.
	 	 	 
	 	(w)	“Indemnified
    Party” has the meaning set forth Section 5.03.
	 	 	 
	 	(x)	“Indemnifying
    Party” has the meaning set forth Section 5.03.
	 	 	 
	 	(y)	“Law”
    means any domestic or foreign, federal, state, municipality or local law, statute, ordinance, code, rule, or regulation.
	 	 	 
	 	(z)	“Lien”
    means any mortgage, lien, pledge, charge, security interest or encumbrance of any kind in respect of such asset, and any conditional
    sale or voting agreement or proxy, including any agreement to give any of the foregoing.

 

    	 2

     

    

 

	 	(aa)	“Losses”
    and “Loss” has the meaning set forth in Section 5.01.
	 	 	 
	 	(bb)	“Non-U.S.
    Person” has the meaning set forth in Section 3.07(b).
	 	 	 
	 	(cc)	“Order”
    means any decree, order, judgment, writ, award, injunction, rule, injunction, stay, decree, judgment or restraining order or consent
    of or by an Authority.
	 	 	 
	 	(dd)	“Party”
    and “Parties” have the meanings set forth in the introductory paragraph hereto.
	 	 	 
	 	(ee)	“Person”
    means an individual, corporation, partnership (including a general partnership, limited partnership or limited liability partnership),
    limited liability company, association, trust or other entity or organization, including a government, domestic or foreign, or political
    subdivision thereof, or an agency or instrumentality thereof.
	 	 	 
	 	(ff)	“Regulation
    S” has the meaning set forth in Section 3.07(f).
	 	 	 
	 	(gg)	“Rule
    144” has the meaning set forth in Section 3.07(f).
	 	 	 
	 	(hh)	“Securities
    Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
	 	 	 
	 	(ii)	“Shareholders’
    Representative” has the meaning set forth in the introductory paragraph hereto.
	 	 	 
	 	(jj)	“Tax(es)”
    means any federal, state, local or foreign tax, charge, fee, levy, custom, duty, deficiency, or other assessment of any kind or nature
    imposed by any Taxing Authority (including any income (net or gross), gross receipts, profits, windfall profit, sales, use, goods
    and services, ad valorem, franchise, license, withholding, employment, social security, workers compensation, unemployment compensation,
    employment, payroll, transfer, excise, import, real property, personal property, intangible property, occupancy, recording, minimum,
    alternative minimum, environmental or estimated tax), including any liability therefor as a transferee (including under Section 6901
    of the Code or similar provision of applicable Law) or successor, as a result of Treasury Regulation Section 1.1502-6 or similar
    provision of applicable Law or as a result of any Tax sharing, indemnification or similar agreement, together with any interest,
    penalty, additions to tax or additional amount imposed with respect thereto.
	 	 	 
	 	(kk)	“Taxing
    Authority” means the Internal Revenue Service and any other Authority responsible for the collection, assessment or imposition
    of any Tax or the administration of any Law relating to any Tax.
	 	 	 
	 	(ll)	“Third-Party
    Claim” has the meaning set forth in Section 5.03(a).
	 	 	 
	 	(mm)	“Transaction
    Documents” means this Agreement and any other document entered into in connection with the transactions contemplated herein.
	 	 	 
	 	(nn)	“Transactions”
    means the transactions contemplated by the Transaction Documents.

 

    	 3

     

    

 

Section 1.02 Interpretive
Provisions. Unless otherwise indicated (i) all references herein to Articles, Sections, Annexes, Exhibits or Schedules, shall be
deemed to refer to Articles, Sections, Annexes, Exhibits or Schedules of or to this Agreement, as applicable; (ii) the words “include,”
“includes” and “including,” when used herein, shall be deemed, in each case, to be followed by the words “without
limitation”; (iii) the headings set forth in this Agreement are for convenience of reference purposes only and shall not affect
or be deemed to affect in any way the meaning or interpretation of this Agreement or any term or provision hereof, (iv) all references
herein to the Subsidiaries of a Person shall be deemed to include all direct and indirect Subsidiaries of such Person; (v) whenever the
context may require, any pronouns used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the
singular form of nouns and pronouns shall include the plural, and vice versa; (vi) any dollar or percentage thresholds set forth herein
shall not be used as a benchmark for the determination of what is or is not “material” or a “Company Material Adverse
Effect” under this Agreement; (vii) the word “extent” and the phrase “to the extent” shall mean the degree
to which a subject or other thing extends, and such word or phrase shall not simply mean “if”; (viii) all references in this
Agreement to dollar amounts and to “$” are intended to refer to U.S. dollars; (ix) any reference to a law or statute shall
include such law or statute, as amended (including by succession of comparable successor statutes), and the rules and regulations promulgated
thereunder, or any successor statute, rules or regulations thereto, unless the context requires otherwise; (x) the words “hereof”,
“herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement
as a whole and not to any particular provision of this Agreement; (xi) unless otherwise expressly provided, wherever the consent of any
Person is required or permitted herein, such consent may be withheld in such Person’s sole and absolute discretion; (xii) unless
the context otherwise requires “or” is disjunctive but not necessarily exclusive; (xiii) references to any Person include
the successors and permitted assigns of that Person; (xiv) references from or through any date mean, unless otherwise specified, from
and including or through and including, respectively; and (xv) if any action under this Agreement is required to be done or taken on
a day that is not a Business Day, then such action shall be required to be done or taken not on such day but on the first succeeding
Business Day thereafter.

 

Article
II. SHARE EXCHANGE

 

Section
2.01 The Exchange.

 

	 	(a)	On
    the terms and subject to the conditions set forth in this Agreement, the HeartCore Shareholders, who hold an aggregate of 10,706
    shares of HeartCore’s shares as authorized in the Articles of HeartCore (the “HeartCore Shares”) representing approximately
    97.47% of HeartCore’s issued and outstanding capital stock of HeartCore, shall sell, assign, transfer and deliver to the Company,
    free and clear of all liens, pledges, encumbrances, charges, restrictions or known claims of any kind, nature, or description, all
    of the HeartCore Shares held by them, as set forth herein. The number of HeartCore Shares held by each of the HeartCore Shareholders
    as of the Closing Date is as set forth in on Exhibit A attached hereto, in the column entitled “HeartCore Shares Owned”.
	 	 	 
	 	(b)	The
    exchange as set forth in this Article II, subject to the other terms and conditions herein, is referred to collectively herein as
    the “Exchange.”

 

Section
2.02 Closing. The closing of the transactions as set forth herein shall occur on the Closing Date, immediately following the
execution of this Agreement. On the Closing Date the Company shall acquire from each HeartCore Shareholder the number of HeartCore
Shares owned by each such HeartCore Shareholder as set forth on Exhibit A in accordance with the provisions herein (the
“Closing”). At the Closing the HeartCore Shareholders shall, on transfer of their respective HeartCore Shares to the
Company, be recorded in the stock ledger of the Company as the owners of the applicable portion of the total Exchange Shares (as
defined below).

 

    	 4

     

    

 

Section 2.03 Issuance.
In exchange for the HeartCore Shares, the Company shall issue to the HeartCore Shareholders a total of 15,999,994 shares of Company
Common Stock, to be apportioned between the HeartCore Shareholders as set forth on Exhibit A in the column entitled “Shares of
Company Stock to be Issued”. The shares of Company Common Stock to be issued to the HeartCore Shareholders at the Closing are
referred to as the “Exchange Shares”.

 

Section
2.04 HeartCore Shareholders’ Deliverables at the Closing. At the Closing, each of the HeartCore Shareholders shall
deliver to the Company stock powers or such other instruments of transfer duly executed in blank and with all required stock
transfer stamps affixed, in form and substance satisfactory to the Company as required for the ownership of the HeartCore Shares to
be transferred to the Company, free and clear of all Liens, with all necessary transfer Tax and other revenue stamps, acquired at
the applicable HeartCore Shareholder’s expense, affixed, and together with such other documents and instruments as required
pursuant to the Companies Act to vest ownership of the HeartCore Shares in the Company.

 

Section
2.05 Company Actions at the Closing. At the Closing, the Company shall record each HeartCore Shareholder as the owner of the
applicable portion of the Exchange Shares delivered at the Closing, in accordance with Section 2.03, in the books and records of the
Company (with the Parties acknowledging that the Exchange Shares shall not be certificated).

 

Section
2.06 Tax Consequences. For U.S. federal income tax purposes, the Exchange is intended to qualify as a
“reorganization” within the meaning of Section 368(a) of the Code and the Treasury Regulations promulgated thereunder.
For the avoidance of doubt, the Parties intent to treat this Exchange as a “Type-B” reorganization under Section
368(a)(1)(B) of the Code. The Parties adopt this Agreement as a “plan of reorganization” within the meaning of Treasury
Regulations Sections 1.368-2(g) and 1.368-3(a).

 

Section
2.07 Additional Documents. At and following the Closing, the Company, the Shareholders’ Representative and the
HeartCore Shareholders shall execute, acknowledge, and deliver (or shall ensure to be executed, acknowledged, and delivered), any
and all certificates, opinions, financial statements, schedules, agreements, resolutions, rulings or other instruments required by
this Agreement to be so delivered at or prior to the Closing, together with such other items as may be reasonably requested by the
Parties and their respective legal counsel in order to effectuate or evidence the transactions contemplated hereby.

 

Article
III. REPRESENTATIONS AND WARRANTIES OF THE HEARTCORE
SHAREHOLDERS

 

As
an inducement to, and to obtain the reliance of the Company, each HeartCore Shareholder, severally and not jointly and severally, and
solely with respect to the HeartCore Shares held by such HeartCore Shareholder and with respect to the Exchange Shares to be received
in connection therewith) represents and warrants to the Company, as of the Closing Date, as follows:

 

Section
3.01 Existence and Power. Such HeartCore Shareholder is a natural person or is an entity duly organized, validly existing,
and in good standing under the Laws of the jurisdiction of organization and has the corporate power and is duly authorized under all
applicable Laws, regulations, ordinances, and orders of public authorities to carry on its business in all material respects as it
is now being conducted.

 

    	 5

     

    

 

Section
3.02 Due Authorization. If such HeartCore Shareholder is an entity, the execution, delivery and performance of this Agreement
by such HeartCore Shareholder does not, and the consummation of the transactions contemplated hereby will not, violate any provision
of its organizational documents. Such HeartCore Shareholder has taken all actions required by Law, its organizational documents, if
applicable, or otherwise to authorize the execution, delivery and performance of this Agreement and to consummate the transactions
herein contemplated.

 

Section
3.03 Valid Obligation. This Agreement and all agreements and other documents executed by such HeartCore Shareholder in connection
herewith constitute the valid and binding obligations of such HeartCore Shareholder, enforceable in accordance with its or their terms,
except as may be limited by bankruptcy, insolvency, moratorium or other similar Laws affecting the enforcement of creditors’ rights
generally and subject to the qualification that the availability of equitable remedies is subject to the discretion of the court before
which any proceeding therefore may be brought.

 

Section
3.04 Governmental Authorization. Neither the execution, delivery nor performance of this Agreement by such HeartCore
Shareholder requires any consent, approval, license or other action by or in respect of, or registration, declaration or filing with
any Authority.

 

Section
3.05 Title to HeartCore Shares. Such HeartCore Shareholder is the record and beneficial owner and holder of the HeartCore
Shares as set forth in Exhibit A, free and clear of all Liens and none of such HeartCore Shares is subject to pre-emptive or similar
rights, either pursuant to any requirement of Law or any contract, and no Person has any pre-emptive rights or similar rights to
purchase or receive any such HeartCore Shares or other interests in HeartCore from such HeartCore Shareholder.

 

Section 3.06 No
Conflict With Other Instruments. The execution of this Agreement and the consummation of the transactions contemplated by this
Agreement by such HeartCore Shareholder will not result in the breach of any term or provision of, constitute a default under, or
terminate, accelerate or modify the terms of, any indenture, mortgage, deed of trust, or other material agreement or instrument to
which such HeartCore Shareholder is a party or to which any of its assets, properties or operations are subject.

 

Section
3.07 Investment Representations. For purposes of this Section 3.07, any reference to the “Exchange Shares” shall be
deemed solely to be a reference to the portion of the Exchange Shares being delivered to such applicable HeartCore Shareholder.

 

	 	(a)	Investment
    Purpose. Such HeartCore Shareholder understands and agrees that the consummation of this Agreement including the delivery of
    the Exchange Shares to such HeartCore Shareholder in exchange for the HeartCore Shares held by such HeartCore Shareholder as contemplated
    hereby, constitutes the offer and sale of securities under the Securities Act and applicable state statutes and that the Exchange
    Shares being acquired by such HeartCore Shareholder are being acquired by such HeartCore Shareholder for such HeartCore Shareholder’s
    own account and not with a present view towards the public sale or distribution thereof, except pursuant to sales registered or exempted
    from registration under the Securities Act.

 

    	 6

     

    

 

	 	(b)	Investor
    Status. Such HeartCore Shareholder is a Non-U.S. Person. A “Non-U.S. Person” means any person who is not (1)
    any natural person resident in the United States (as defined below); (2) any partnership or corporation organized or incorporated
    under the laws of the United States; (3) any estate of which any executor or administrator is a United States person; (4) any trust
    of which any trustee is a United States person; (5) any agency or branch of a foreign entity located in the United States; (6) any
    non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit
    or account of a United States person; (7) any discretionary account or similar account (other than an estate or trust) held by a
    dealer or other fiduciary organized, incorporated, or (if an individual) resident of the United States; or (8) any partnership or
    corporation if (1) organized or incorporated under the laws of any foreign jurisdiction and (2) formed by a United States person
    principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated,
    and owned, by accredited investors (as defined in Rule 501 under Regulation D pursuant to the Securities Act) who are not natural
    persons, estates or trusts.
	 	 	 
	 	(c)	Reliance
    on Exemptions. Such HeartCore Shareholder understands that the Exchange Shares are being offered and sold to such HeartCore Shareholder
    in reliance upon specific exemptions from the registration requirements of United States federal and state securities Laws and that
    the Company is relying upon the truth and accuracy of, and such HeartCore Shareholder’s compliance with, the representations,
    warranties, agreements, acknowledgments and understandings of such HeartCore Shareholder set forth herein in order to determine the
    availability of such exemptions and the eligibility of such HeartCore Shareholder to acquire the Exchange Shares.
	 	 	 
	 	(d)	Information.
    Such HeartCore Shareholder and such HeartCore Shareholder’s advisors, if any, have been furnished with all materials relating
    to the business, finances and operations of the Company and materials relating to the offer and sale of the Exchange Shares which
    have been requested by such HeartCore Shareholder or Such HeartCore Shareholder’s advisors. Such HeartCore Shareholder and
    Such HeartCore Shareholder’s advisors, if any, have been afforded the opportunity to ask questions of the Company. Such HeartCore
    Shareholder understands that Such HeartCore Shareholder’s investment in the Exchange Shares involves a significant degree of
    risk. Such HeartCore Shareholder is not aware of any facts that may constitute a breach of any of the Company’s representations
    and warranties made herein.
	 	 	 
	 	(e)	Governmental
    Review. Such HeartCore Shareholder understands that no United States federal or state agency or any other government or governmental
    agency has passed upon or made any recommendation or endorsement of the Exchange Shares.

 

    	 7

     

    

 

	 	(f)	Transfer
    or Resale. Such HeartCore Shareholder understands that (i) the sale or re-sale of the Exchange Shares has not been and is not
    being registered under the Securities Act or any applicable state securities Laws, and the Exchange Shares may not be transferred
    unless (a) the Exchange Shares are sold pursuant to an effective registration statement under the Securities Act, (b) such HeartCore
    Shareholder shall have delivered to the Company, at the cost of such HeartCore Shareholder, an opinion of counsel that shall be in
    form, substance and scope customary for opinions of counsel in comparable transactions to the effect that the Exchange Shares to
    be sold or transferred may be sold or transferred pursuant to an exemption from such registration, which opinion shall be accepted
    by the Company, (c) the Exchange Shares are sold or transferred to an “affiliate” (as defined in Rule 144 promulgated
    under the Securities Act (or a successor rule) (“Rule 144”)) of such HeartCore Shareholder who agree to sell or otherwise
    transfer the Exchange Shares only in accordance with this Section 3.07 and who is an accredited investor (as defined in Rule 501
    under Regulation D pursuant to the Securities Act), (d) the Exchange Shares are sold pursuant to Rule 144, or (e) the Exchange Shares
    are sold pursuant to Regulation S under the Securities Act (or a successor rule) (“Regulation S”), and such HeartCore
    Shareholder shall have delivered to the Company, at the cost of such HeartCore Shareholder, an opinion of counsel that shall be in
    form, substance and scope customary for opinions of counsel in corporate transactions, which opinion shall be accepted by the Company;
    (ii) any sale of such Exchange Shares made in reliance on Rule 144 may be made only in accordance with the terms of said Rule and
    further, if said Rule is not applicable, any re-sale of such Exchange Shares under circumstances in which the seller (or the person
    through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the Securities Act) may require compliance
    with some other exemption under the Securities Act or the rules and regulations of the United States Securities and Exchange Commission
    thereunder; and (iii) neither the Company nor any other person is under any obligation to register such Exchange Shares under the
    Securities Act or any state securities Laws or to comply with the terms and conditions of any exemption thereunder (in each case).
    Notwithstanding the foregoing or anything else contained herein to the contrary, the Exchange Shares may be pledged as collateral
    in connection with a bona fide margin account or other lending arrangement.
	 	 	 
	 	(g)	Legends.
    Such HeartCore Shareholder understands that the Exchange Shares, until such time as the Exchange Shares have been registered under
    the Securities Act, or may be sold pursuant to Rule 144 or Regulation S without any restriction as to the number of securities as
    of a particular date that can then be immediately sold, the Exchange Shares may bear a standard Rule 144 legend and a stop-transfer
    order may be placed against transfer of the certificates for such Exchange Shares.
	 	 	 
	 	(h)	Removal.
    The legend(s) referenced in Section 3.07(g) shall be removed and the Company shall issue a certificate without such legend to the
    holder of any Exchange Shares upon which it is stamped, if, unless otherwise required by applicable state securities Laws, (a) the
    Exchange Shares are registered for sale under an effective registration statement filed under the Securities Act or otherwise may
    be sold pursuant to Rule 144 or Regulation S without any restriction as to the number of securities as of a particular date that
    can then be immediately sold, or (b) such holder provides the Company with an opinion of counsel, in form, substance and scope customary
    for opinions of counsel in comparable transactions, to the effect that a public sale or transfer of such Exchange Shares may be made
    without registration under the Securities Act, which opinion shall be accepted by the Company so that the sale or transfer is effected.
    Such HeartCore Shareholder agrees to sell all Exchange Shares, including those represented by a certificate(s) from which the legend
    has been removed, in compliance with applicable prospectus delivery requirements, if any.

 

    	 8

     

    

 

Article
IV. REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

As
an inducement to, and to obtain the reliance of the HeartCore Shareholders, the Company represents and warrants to the HeartCore Shareholders,
as of the Closing Date, as follows:

 

Section
4.01 Corporate Existence and Power. The Company is a corporation duly organized, validly existing, and in good standing under
the Laws of the State of Delaware and has the corporate power and is duly authorized under all applicable Laws, regulations, ordinances,
and orders of public authorities to carry on its business in all material respects as it is now being conducted. The execution and delivery
of this Agreement does not, and the consummation of the transactions contemplated hereby will not, violate any provision of the Company
Organizational Documents. The Company has taken all action required by Law, the Company Organizational Documents, or otherwise to authorize
the execution and delivery of this Agreement, and the Company has full power, authority, and legal right and has taken all action required
by Law, the Company Organizational Documents or otherwise to consummate the transactions herein contemplated.

 

Section
4.02 Due Authorization.The execution, delivery and performance of this Agreement does not, and the consummation of the transactions
contemplated hereby will not, violate any provision of the Company Organizational Documents. The Company has taken all actions required
by Law, the Company Organizational Documents or otherwise to authorize the execution, delivery and performance of this Agreement and
to consummate the transactions herein contemplated.

 

Section
4.03 Valid Obligation. This Agreement and all agreements and other documents executed by the Company in connection herewith constitute
the valid and binding obligations of the Company, enforceable in accordance with its or their terms, except as may be limited by bankruptcy,
insolvency, moratorium or other similar Laws affecting the enforcement of creditors’ rights generally and subject to the qualification
that the availability of equitable remedies is subject to the discretion of the court before which any proceeding therefore may be brought.

 

Section 4.04 Governmental
Authorization. Neither the execution, delivery nor performance of this Agreement by the Company requires any consent, approval,
license or other action by or in respect of, or registration, declaration or filing with any Authority.

 

Section
4.05 No Conflict With Other Instruments. The execution of this Agreement and the consummation of the transactions contemplated
by this Agreement will not result in the breach of any term or provision of, constitute a default under, or terminate, accelerate or
modify the terms of, any indenture, mortgage, deed of trust, or other material agreement or instrument to which the Company is a party
or to which any of its assets, properties or operations are subject.

 

Section
4.06 Approval of Agreement. The Board of Directors of the Company has authorized the execution and delivery of this Agreement
by the Company and has approved this Agreement and the transactions contemplated hereby.

 

Article
V. INDEMNIFICATION

 

Section 5.01 Indemnification
of Company. Each HeartCore Shareholder, severally and not jointly and severally, hereby agrees to indemnify and hold harmless to
the fullest extent permitted by applicable law the Company, each of its Affiliates and each of its and their respective members,
managers, partners, directors, officers, employees, stockholders, attorneys and agents and permitted assignees and the
Shareholders’ Representative (each a “Company Indemnified Party”), against and in respect of any and all
out-of-pocket loss, cost, payments, demand, penalty, forfeiture, expense, liability, judgment, deficiency or damage, and diminution
in value or claim (including actual costs of investigation and attorneys’ fees and other costs and expenses) (all of the
foregoing collectively, “Losses” and each individually a “Loss”) incurred or sustained by any Company
Indemnified Party as a result of or in connection with any breach, inaccuracy or nonfulfillment or the alleged breach, inaccuracy or
nonfulfillment of any of the representations, warranties, covenants and agreements of such HeartCore Shareholder contained herein or
in any of the additional agreements or any certificate or other writing delivered pursuant hereto.

 

    	 9

     

    

 

Section
5.02 Indemnification of the HeartCore Shareholders. The Company hereby agrees to indemnify and hold harmless to the fullest
extent permitted by applicable law the Shareholders’ Representative and the HeartCore Shareholders (each a “HeartCore
Indemnified Party”), against and in respect of any and all Losses incurred or sustained by any HeartCore Indemnified Party as
a result of or in connection with any breach, inaccuracy or nonfulfillment or the alleged breach, inaccuracy or nonfulfillment of
any of the representations, warranties, covenants and agreements of the Company contained herein or in any of the additional
agreements or any certificate or other writing delivered pursuant hereto.

 

Section 5.03 Procedure.
The following shall apply with respect to all claims by any HeartCore Indemnified Party or Company Indemnified Party for
indemnification with respect to actions by third-parties (with any references herein to an “Indemnified Party” being a
reference to a HeartCore Indemnified Party or a Company Indemnified Party, as applicable, and any references herein to an
“Indemnifying Party” being a reference to the Company or the HeartCore Shareholders, as applicable):

 

	 	(a)	Third-Party
    Claims. If any Indemnified Party receives notice of the assertion or commencement of any Action made or brought by any Person
    who is not a party to this Agreement or an Affiliate of a party to this Agreement or a Representative of the foregoing (a “Third-Party
    Claim”) against such Indemnified Party with respect to which the Indemnifying Party is obligated to provide indemnification
    under this Agreement, the Indemnified Party shall give the Indemnifying Party reasonably prompt written notice thereof, but in any
    event not later than thirty (30) calendar days after receipt of such notice of such Third-Party Claim. The failure to give such prompt
    written notice shall not, however, relieve the Indemnifying Party of its indemnification obligations, except and only to the extent
    that the Indemnifying Party forfeits rights or defenses by reason of such failure. Such notice by the Indemnified Party shall describe
    the Third-Party Claim in reasonable detail, shall include copies of all material written evidence thereof and shall indicate the
    estimated amount, if reasonably practicable, of the Loss that has been or may be sustained by the Indemnified Party. The Indemnifying
    Party shall have the right to participate in, or by giving written notice to the Indemnified Party, to assume the defense of any
    Third-Party Claim at the Indemnifying Party’s expense and by the Indemnifying Party’s own counsel, and the Indemnified
    Party shall cooperate in good faith in such defense. In the event that the Indemnifying Party assumes the defense of any Third-Party
    Claim, subject to Section 5.03(b), it shall have the right to take such action as it deems necessary to avoid, dispute, defend, appeal
    or make counterclaims pertaining to any such Third-Party Claim in the name and on behalf of the Indemnified Party. The Indemnified
    Party shall have the right to participate in the defense of any Third-Party Claim with counsel selected by it subject to the Indemnifying
    Party’s right to control the defense thereof, provided that the fees and disbursements of such counsel shall be at the expense
    of the Indemnified Party.

 

    	 10

     

    

 

	 	(b)	Settlement
    of Third-Party Claims. Notwithstanding any other provision of this Agreement, the Indemnifying Party shall not enter into settlement
    of any Third-Party Claim without the prior written consent of the Indemnified Party, except as provided in this Section 5.03(b).
    If a firm offer is made to settle a Third-Party Claim without leading to liability or the creation of a financial or other obligation
    on the part of the Indemnified Party and provides, in customary form, for the unconditional release of each Indemnified Party from
    all liabilities and obligations in connection with such Third-Party Claim and the Indemnifying Party desires to accept and agree
    to such offer, the Indemnifying Party shall give written notice to that effect to the Indemnified Party. If the Indemnified Party
    fails to consent to such firm offer within ten days after its receipt of such notice, the Indemnified Party may continue to contest
    or defend such Third-Party Claim and in such event, the maximum liability of the Indemnifying Party as to such Third-Party Claim
    shall not exceed the amount of such settlement offer. If the Indemnified Party fails to consent to such firm offer and also fails
    to assume defense of such Third-Party Claim, the Indemnifying Party may settle the Third-Party Claim upon the terms set forth in
    such firm offer to settle such Third-Party Claim. If the Indemnified Party has assumed the defense pursuant to Section 5.03(a), it
    shall not agree to any settlement without the written consent of the Indemnifying Party (which consent shall not be unreasonably
    withheld or delayed).
	 	 	 
	 	(c)	Direct
    Claims. Any Action by an Indemnified Party on account of a Loss which does not result from a Third-Party Claim (a “Direct
    Claim”) shall be asserted by the Indemnified Party giving the Indemnifying Party reasonably prompt written notice thereof,
    but in any event not later than thirty (30) calendar days after the Indemnified Party becomes aware of such Direct Claim. The failure
    to give such prompt written notice shall not, however, relieve the Indemnifying Party of its indemnification obligations, except
    and only to the extent that the Indemnifying Party forfeits rights or defenses by reason of such failure. Such notice by the Indemnified
    Party shall describe the Direct Claim in reasonable detail, shall include copies of all material written evidence thereof and shall
    indicate the estimated amount, if reasonably practicable, of the Loss that has been or may be sustained by the Indemnified Party.
    The Indemnifying Party shall have thirty (30) calendar days after its receipt of such notice to respond in writing to such Direct
    Claim. The Indemnified Party shall allow the Indemnifying Party and its professional advisors to investigate the matter or circumstance
    alleged to give rise to the Direct Claim, and whether and to what extent any amount is payable in respect of the Direct Claim and
    the Indemnified Party shall assist the Indemnifying Party’s investigation by giving such information and assistance as the
    Indemnifying Party or any of its professional advisors may reasonably request. If the Indemnifying Party does not so respond within
    such thirty (30) calendar day period, the Indemnifying Party shall be deemed to have rejected such claim, in which case the Indemnified
    Party shall be free to pursue such remedies as may be available to the Indemnified Party on the terms and subject to the provisions
    of this Agreement.
	 	 	 
	 	(d)	Cooperation.
    Upon a reasonable request made by the Indemnifying Party, each Indemnified Party seeking indemnification hereunder in respect of
    any Direct Claim, hereby agrees to consult with the Indemnifying Party and act reasonably to take actions reasonably requested by
    the Indemnifying Party in order to attempt to reduce the amount of Losses in respect of such Direct Claim. Any costs or expenses
    associated with taking such actions shall be included as Losses hereunder.

 

Section 5.04 Periodic
Payments. Any indemnification required by this Article V for costs, disbursements or expenses of any Indemnified Party in
connection with investigating, preparing to defend or defending any Action shall be made by periodic payments by the Indemnifying
Party to each Indemnified Party during the course of the investigation or defense, as and when bills are received or costs,
disbursements or expenses are incurred.

 

    	 11

     

    

 

Section 5.05 Insurance.
Any indemnification payments hereunder shall take into account any insurance proceeds or other third-party reimbursement actually
received.

 

Section 5.06 Limitations.

 

	 	(a)	The
    obligations of the HeartCore Shareholders and the Company under Section 5.01 and Section 5.02 shall expire in two (2) years from
    the Closing Date, except with respect to (i) an indemnification claim asserted in accordance with the provisions of this Article
    V which remains unresolved, for which the obligation to indemnify shall continue until such claim is resolved; and (ii) resolved
    claims for which payment has not yet been paid to the Indemnified Party.
	 	 	 
	 	(b)	The
    aggregate amount of all Losses for which each of the HeartCore Shareholders shall be liable pursuant to Section 5.01 shall in no
    event exceed the value of the HeartCore Shares such HeartCore Shareholder transferred to the Company. Notwithstanding the provisions
    of Section 5.01, if and to the extent the HeartCore Shares are validly transferred by any of the HeartCore Shareholders to the Company
    pursuant to the provisions of Article II of this Agreement, such HeartCore Shareholder shall not be required to indemnify any of
    the Company Indemnified Parties for any Losses incurred or sustained by any of the Company Indemnified Parties as a result of or
    in connection with any breach, inaccuracy or nonfulfillment or the alleged breach, inaccuracy or nonfulfillment of any of the representations
    and warranties of such HeartCore Shareholder contained herein.
	 	 	 
	 	(c)	Each
    Indemnified Party shall take, and cause its Affiliates to take, all reasonable steps to mitigate any Loss upon becoming aware of
    any event or circumstance that would be reasonably expected to, or does, give rise thereto, including incurring costs only to the
    minimum extent necessary to remedy the breach that gives rise to such Loss.
	 	 	 
	 	(d)	The
    HeartCore Shareholders shall not be liable under the provisions of this for any Losses based upon or arising out of any inaccuracy
    in or breach of any of the representations or warranties of the HeartCore Shareholders contained herein if any of the Company Indemnified
    Parties had knowledge of or could have known such inaccuracy or breach prior to the Closing.

 

Section
5.07 Exclusive Remedy. The indemnification provisions contained in this Article V shall be the sole and exclusive remedy of
the Parties with respect to the transactions contemplated herein for any and all breaches or alleged breaches of any
representations, warranties, covenants or agreements of the Parties hereto or any other provision of this Agreement or arising out
of the transactions contemplated herein, except (i) with respect to any equitable remedy to which such Party may be entitled to with
respect to any claims or causes of action arising from the breach of any covenants or agreement of a Party that is to be performed
subsequent to the Closing Date, or (ii) with respect to a Party, an actual and intentional fraud with respect to this Agreement and
the transactions contemplated herein.

 

    	 12

     

    

 

Article
VI. MISCELLANEOUS

 

Section 6.01 Governing
Law. This Agreement shall be governed by, enforced, and construed under and in accordance with the Laws of the State of
Delaware, without giving effect to the principles of conflicts of law thereunder. Each of the Parties (a) irrevocably consents and
agrees that any legal or equitable action or proceedings arising under or in connection with this Agreement shall be brought
exclusively in either (i) the state or federal courts of the United States with jurisdiction in Palm Beach County, Florida or (ii)
the Tokyo District Court. By execution and delivery of this Agreement, each Party hereto irrevocably submits to and accepts, with
respect to any such action or proceeding, generally and unconditionally, the jurisdiction of the aforesaid courts, and irrevocably
waives any and all rights such Party may now or hereafter have to object to such jurisdiction.

 

Section
6.02 Waiver of Jury Trial.

 

	 	(a)	EACH
    PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL
    PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREIN (WHETHER BASED
    ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY
    HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING
    WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS,
    THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS Section 6.02(a).
	 	 	 
	 	(b)	Each
    of the Parties acknowledge that each has been represented in connection with the signing of this waiver by independent legal counsel
    selected by the respective Party and that such Party has discussed the legal consequences and import of this waiver with legal counsel.
    Each of the Parties further acknowledge that each has read and understands the meaning of this waiver and grants this waiver knowingly,
    voluntarily, without duress and only after consideration of the consequences of this waiver with legal counsel.

 

Section 6.03 Limitation
on Damages. In no event will any Party be liable to any other Party under or in
connection with this Agreement or in connection with the Transactions for special, general, indirect or consequential damages,
including damages for lost profits or lost opportunity, even if the Party sought to be held liable has been advised of the
possibility of such damage.

 

Section 6.04 Brokers.
The Company and each HeartCore Shareholder agree that there were no finders or brokers involved in bringing the Parties together or
who were instrumental in the negotiation, execution or consummation of this Agreement. The Company and each HeartCore Shareholder
each agree to indemnify the other against any claim by any third person other than those described above for any commission,
brokerage, or finder’s fee arising from the transactions contemplated hereby based on any alleged agreement or understanding
between the Indemnifying Party and such third person, whether express or implied from the actions of the Indemnifying
Party.

 

    	 13

     

    

 

Section 6.05 Notices.

 

	 	(a)	Any
    notice or other communications required or permitted hereunder shall be in writing and shall be sufficiently given if personally
    delivered to it or sent by email, overnight courier or registered mail or certified mail, postage prepaid, addressed as follows:

 

If
to the Company or to the Shareholders’ Representative, to:

 

HeartCore
Enterprises, Inc.

Attn:
Sumitaka Yamamoto

1-2-33,
Higashigotanda, Shinagawa-ku

Tokyo,
Japan

Email:
kanno@heartcore.co.jp

 

With
a copy, which shall not constitute notice, to:

 

Anthony
L.G., PLLC

Attn:
John Cacomanolis

625
N. Flagler Drive, Suite 600

West
Palm Beach, FL 33401

Email:
jcacomanolis@anthonypllc.com

 

If
to any HeartCore Shareholder, to the address as set forth on Exhibit A attached hereto.

 

	 	(b)	Any
    Party may change its address for notices hereunder upon notice to each other Party in the manner for giving notices hereunder.
	 	 	 
	 	(c)	Any
    notice hereunder shall be deemed to have been given (i) upon receipt, if personally delivered, (ii) on the day after dispatch, if
    sent by overnight courier, (iii) upon dispatch, if transmitted by email with return receipt requested and received and (iv) three
    (3) days after mailing, if sent by registered or certified mail.

 

Section
6.06 Attorneys’ Fees. In the event that any Party institutes any action or suit to enforce this Agreement or to secure
relief from any default hereunder or breach hereof, the prevailing Party shall be reimbursed by the losing Party for all costs,
including reasonable attorney’s fees, incurred in connection therewith and in enforcing or collecting any judgment rendered
therein.

 

Section
6.07 Confidentiality. Each Party agrees that, unless and until the transactions contemplated by this Agreement have been
consummated, it and its representatives will hold in strict confidence all data and information obtained with respect to another
Party or any subsidiary thereof from any representative, officer, director or employee, or from any books or records or from
personal inspection, of such other Party, and shall not use such data or information or disclose the same to others, except (i) to
the extent such data or information is published, is a matter of public knowledge, or is required by Law to be published; or (ii) to
the extent that such data or information must be used or disclosed in order to consummate the transactions contemplated by this
Agreement. In the event of the termination of this Agreement, each Party shall return to the applicable other Party all documents
and other materials obtained by it or on its behalf and shall destroy all copies, digests, work papers, abstracts or other materials
relating thereto, and each Party will continue to comply with the confidentiality provisions set forth herein.

 

Section 6.08 Third
Party Beneficiaries. This contract is strictly between the Company, the HeartCore Shareholders and the Shareholders’
Representative, and except as specifically provided herein, no other Person and no director, officer, stockholder (other than the
HeartCore Shareholders), employee, agent, independent contractor or any other Person shall be deemed to be a third-party beneficiary
of this Agreement.

 

    	 14

     

    

 

Section 6.09 Expenses.
Subject to Article V and Section 6.06, whether or not the Exchange is consummated, each of the Company and each HeartCore
Shareholder will bear their own respective expenses, including legal, accounting and professional fees, incurred in connection with
the Exchange or any of the other transactions contemplated hereby.

 

Section
6.10 Entire Agreement. This Agreement represents the entire agreement between the Parties relating to the subject matter
thereof and supersedes all prior agreements, understandings and negotiations, written or oral, with respect to such subject
matter.

 

Section
6.11 Survival. The representations, warranties, and covenants of the respective Parties shall survive the Closing Date and
the consummation of the Transactions for a period of one year from the latest date thereof.

 

Section 6.12 Amendment;
Waiver; Remedies; Agent.

 

	 	(a)	Other
    than as specifically set forth herein, this Agreement may be amended, modified, superseded, terminated or cancelled, and any of the
    terms, covenants, representations, warranties or conditions hereof may be waived, only by a written instrument executed by the Company
    and the Shareholders’ Representative on behalf of the HeartCore Shareholders, provided, however, that in the event that any
    such amendment, event or action is materially adverse to the rights or obligations of any HeartCore Shareholder(s), such amendment,
    event or action shall be subject to the written approval of the applicable HeartCore Shareholder(s) to whom such amendment, event
    or action is materially adverse.
	 	 	 
	 	(b)	Every
    right and remedy provided herein shall be cumulative with every other right and remedy, whether conferred herein, at law, or in equity,
    and may be enforced concurrently herewith, and no waiver by any Party of the performance of any obligation by the other shall be
    construed as a waiver of the same or any other default then, theretofore, or thereafter occurring or existing.
	 	 	 
	 	(c)	Neither
    any failure or delay in exercising any right or remedy hereunder or in requiring satisfaction of any condition herein nor any course
    of dealing shall constitute a waiver of or prevent any Party from enforcing any right or remedy or from requiring satisfaction of
    any condition. No notice to or demand on a Party waives or otherwise affects any obligation of that Party or impairs any right of
    the Party giving such notice or making such demand, including any right to take any action without notice or demand not otherwise
    required by this Agreement. No exercise of any right or remedy with respect to a breach of this Agreement shall preclude exercise
    of any other right or remedy, as appropriate to make the aggrieved Party whole with respect to such breach, or subsequent exercise
    of any right or remedy with respect to any other breach.
	 	 	 
	 	(d)	Notwithstanding
    anything else contained herein, no Party shall seek, nor shall any Party be liable for, consequential, punitive or exemplary damages,
    under any tort, contract, equity, or other legal theory, with respect to any breach (or alleged breach) of this Agreement or any
    provision hereof or any matter otherwise relating hereto or arising in connection herewith.

 

    	 15

     

    

 

Section
6.13 HeartCore Shareholders’ Representative.

 

	 	(a)	Each
    HeartCore Shareholder constitutes and appoints the Shareholders’ Representative as its representative and its true and lawful
    attorney in fact, with full power and authority in its name and on its behalf:
	 	 	 	 
	 	 	(i)	to
    act on such HeartCore Shareholders’ behalf in the absolute discretion of Shareholders’ Representative with respect to
    all matters relating to this Agreement, including execution and delivery of any amendment, supplement, or modification of this Agreement
    and any waiver of any claim or right arising out of this Agreement or the provision of any consent or agreement hereunder; and
	 	 	 	 
	 	 	(ii)	in
    general, to do all things and to perform all acts, including executing and delivering all agreements, certificates, receipts, instructions,
    and other instruments contemplated by or deemed advisable to effectuate the provisions of this Section 6.13.
	 	 	 	 
	 	(b)	This
    appointment and grant of power and authority is coupled with an interest and is in consideration of the mutual covenants made in
    this Agreement and is irrevocable and will not be terminated by any act of any HeartCore Shareholder or by operation of law, whether
    by the death or incapacity of any HeartCore Shareholder or by the occurrence of any other event. Each HeartCore Shareholder hereby
    consents to the taking of any and all actions and the making of any decisions required or permitted to be taken or made by Shareholders’
    Representative pursuant to this Section 6.13. Each HeartCore Shareholder agrees that Shareholders’ Representative shall have
    no obligation or liability to any Person for any action taken or omitted by Shareholders’ Representative in good faith, even
    if taken or omitted negligently, and each HeartCore Shareholder shall indemnify and hold harmless Shareholders’ Representative
    from, and shall pay to Shareholders’ Representative the amount of, or reimburse Shareholders’ Representative for, any
    Loss that Shareholders’ Representative may suffer, sustain, or become subject to as a result of any claim made or threatened
    against Shareholders’ Representative in his capacity as such.
	 	 	 	 
	 	(c)	The
    Company shall be entitled to rely upon any document or other paper delivered by Shareholders’ Representative as being authorized
    by HeartCore Shareholders, and the Company shall not be liable to any HeartCore Shareholder for any action taken or omitted to be
    taken by the Company based on such reliance.

 

Section 6.14 Arm’s
Length Bargaining; No Presumption Against Drafter. This Agreement has been negotiated at arm’s-length by parties of equal
bargaining strength, each represented by counsel or having had but declined the opportunity to be represented by counsel and having
participated in the drafting of this Agreement. This Agreement creates no fiduciary or other special relationship between the
Parties, and no such relationship otherwise exists. No presumption in favor of or against any Party in the construction or
interpretation of this Agreement or any provision hereof shall be made based upon which Person might have drafted this Agreement or
such provision.

 

Section 6.15 Headings.
The headings contained in this Agreement are intended solely for convenience and shall not affect the rights of the
Parties.

 

Section
6.16 No Assignment or Delegation. No Party may assign any right or delegate any obligation hereunder, including by merger,
consolidation, operation of law, or otherwise, without the written consent of all of the other Parties and any purported assignment
or delegation without such consent shall be null and void and of no force or effect, in addition to constituting a material breach
of this Agreement. This Agreement shall be binding on the permitted successors and assigns of the Parties.

 

    	 16

     

    

 

Section 6.17 Commercially
Reasonable Efforts. Subject to the terms and conditions herein provided, each HeartCore Shareholder and the Company shall use
their respective commercially reasonable efforts to perform or fulfill all conditions and obligations to be performed or fulfilled
by it under this Agreement so that the transactions contemplated hereby shall be consummated as soon as practicable, and to take, or
cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Laws and
regulations to consummate and make effective this Agreement and the transactions contemplated herein.

 

Section 6.18 Further
Assurances. From and after the Closing Date, each Party shall execute and deliver such documents and take such action, as may
reasonably be considered within the scope of such Party’s obligations hereunder, necessary to effectuate the transactions
contemplated by this Agreement.

 

Section
6.19 Specific Performance. The Parties agree that irreparable damage would occur in the event that any of the provisions of
this Agreement were not performed by them in accordance with the terms hereof or were otherwise breached and that each Party hereto
shall be entitled to an injunction or injunctions, specific performance and other equitable relief to prevent breaches of the
provisions hereof and to enforce specifically the terms and provisions hereof, without the proof of actual damages, in addition to
any other remedy to which they are entitled at law or in equity. Each Party agrees to waive any requirement for the security or
posting of any bond in connection with any such equitable remedy, and agrees that it will not oppose the granting of an injunction,
specific performance or other equitable relief on the basis that (a) the other Party has an adequate remedy at law, or (b) an award
of specific performance is not an appropriate remedy for any reason at law or equity.

 

Section 6.20 Counsel.
The Parties acknowledge and agree that Anthony L.G., PLLC (“Counsel”) has acted as legal counsel to the Company and to
HeartCore, that Sumitaka Yamamoto is an officer and director of the Company and HeartCore, and that Counsel is not legal counsel to
any HeartCore Shareholder or Mr. Yamamoto personally, either in connection with this Agreement and the Transactions, or otherwise.
Each of the Parties acknowledges and agrees that they are aware of, and have consented to, the Counsel acting as legal counsel to
the Company and to HeartCore notwithstanding the relationship between the Company, HeartCore and Mr. Yamamoto, and that Counsel has
advised each of the Parties to retain separate counsel to review the terms and conditions of this Agreement and the other documents
to be delivered in connection herewith, and each applicable Party has either waived such right freely or has otherwise sought such
additional counsel as it has deemed necessary. Each of the Parties hereby waives any conflict of interest that may arise as a result
of the relationship between the Company, HeartCore and Mr. Yamamoto, and confirms that the Parties have previously negotiated the
material terms of the agreements as set forth herein.

 

Section
6.21 Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all
of which taken together shall be but a single instrument. The execution and delivery of a facsimile or other electronic transmission
of a signature to this Agreement shall constitute delivery of an executed original and shall be binding upon the person whose
signature appears on the transmitted copy.

 

[Signatures
Appear on Following Page]

 

    	 17

     

    

 

IN
WITNESS WHEREOF, the Parties have executed this Agreement as of the Closing Date.

 

	 	HeartCore
    Enterprises, Inc.
	 	 	                                                      
	 	By:	/s/
    Sumitaka Yamamoto
	 	Name:
    	Sumitaka
    Yamamoto
	 	Title:
    	Chief
    Executive Officer
	 	 	 
	 	Shareholders’
    Representative:
	 	 	 
	 	By:
    	/s/
    Sumitaka Yamamoto
	 	Name:
    	Sumitaka
    Yamamoto

 

	HeartCore
    Shareholders:	 
	 	 	 
	Daishin
    Yasui	 
	 	                                 	 
	By:	/s/
Daishin Yasui	 
	Name:	Daishin
Yasui	 
	 	 	 
	Sumitaka
    Yamamoto	 
	 	 	 
	By:	/s/
Sumitaka Yamamoto	 
	Name:	Sumitaka
Yamamoto	 
	 	 	 
	Information
    Services International-Dentsu, Ltd.	 
	 	 	 
	By:	/s/
Shinichi Ogane	 
	Name:	Shinichi
Ogane	 
	Title:	Senior
Managing Director	 

 

    	 18

     

    

 

	Kuniaki
    Kawaji	 
	 	                                 	 
	By:	/s/
    Kuniaki Kawaji	 
	Name:	Kuniaki
Kawaji	 
	 	 	 
	Ci:z
    Investment LLP	 
	 	 	 
	By:	/s/
Yoshinori Shirono	 
	Name:	Yoshinori
    Shirono	 
	Title:	Functional
Manager	 
	 	 	 
	Ryugo
    Miyake	 
	 	 	 
	By:	/s/
Ryugo Miyake	 
	Name:	Ryugo
Miyake	 
	 	 	 
	Kimio
    Hosaka	 
	 	 	 
	By:	/s/
Kimio Hosaka	 
	Name:	Kimio
Hosaka	 
	 	 	 
	Hidekazu
    Miyata	 
	 	 	 
	By:	/s/
Hidekazu Miyata	 
	Name:	Hidekazu
    Miyata	 
	 	 	 
	Next
    Vision Corporation	 
	 	 	 
	By:	/s/
Takeo Arima	 
	Name:	Takeo
    Arima	 
	Title:
    	President	 

 

	Naoto
    Ikemura	 
	 	 	 
	By:	/s/
    Naoto Ikemura	 
	Name:	Naoto
    Ikemura	 
	 	 	 
	Keisuke
    Kuno	 

 

 

    	 19

     

    

  

	By:	/s/
Keisuke Kuno	 
	Name:	Keisuke
Kuno	 
	 	 	 
	Hisashi
    Yamashiro	 
	 	 	 
	By:	/s/
Hisashi Yamashiro	 
	Name:	Hisashi
Yamashiro	 
	 	 	 
	Jin
    Higa	 
	 	 	 
	By:	/s/
Jin Higa	 
	Name:	Jin
Higa	 
	 	 	 
	Toru
    Ohyama	 
	 	 	 
	By:	/s/
Toru Ohyama	 
	Name:	Toru
Ohyama	 
	 	 	 
	Gou
    Miyazaki	 
	 	 	 
	By:	/s/
Gou Miyazaki	 
	Name:	Gou
Miyazaki	 

  

	Masami
    Takasaki	 
	 	 	 
	By:	/s/
Masami Takasaki	 
	Name:
    	Masami
    Takasaki	 
	 	 	 
	Kou
    Shiba	 
	 	 	 
	By:
    	/s/
    Kou Shiba	 
	Name:	Kou
Shiba	 
	 	 	 
	Naomi
    Sato	 
	 	 	 
	By:	/s/
Naomi Sato	 
	Name:
    	Naomi
    Sato	 
	 	 	 
	Kaoru
    Yagasaki	 
	 	 	 
	By:	/s/
Kaoru Yagasaki  	 
	Name:	Kaoru
Yagasaki	 

 

    	 20

     

    

 

Exhibit
A

 

HeartCore
Shareholders’ HeartCore Shares and Shares of Company Stock to be Issued

 

	Shareholder Name	 	Address for Notices	 	HeartCore Shares Owned	 	 	Shares of Company Stock to be Issued:	 
	Sumitaka Yamamoto	 	848 Jordan Ave. #G Los Altos CA 94022 USA	 	 	8,119	 	 	 	12,133,752	 
	Daishin Yasui	 	387-1301 Koyadocho, Samegai-dori Shijo-sagaru, Shimogyo-ku, Kyoto-shi, Kyoto	 	 	1,556	 	 	 	2,325,425	 
	Information Services International-Dentsu, Ltd.	 	2-17-1 Konan, Minato-ku	 	 	278	 	 	 	415,468	 
	Kuniaki Kawaji	 	4-30-7 Nishitsutsujigaoka, Chofu-shi Kassa Forte 406	 	 	200	 	 	 	298,898	 
	Ci:z Investment LLP	 	13-1-H602 Uguisudani, Shibuya-ku, Tokyo	 	 	200	 	 	 	298,898	 
	Ryugo Miyake	 	4-23-17-213 Meguro, Meguro-ku, Tokyo	 	 	120	 	 	 	179,339	 
	Kimio Hosaka	 	2-16-2-312 Oshiage, Sumida-ku, Tokyo	 	 	60	 	 	 	89,669	 
	Hidekazu Miyata	 	4-6-6-1106, Konan, Minato-ku, Tokyo	 	 	40	 	 	 	59,780	 
	Next Vision Corporation	 	2-15 Enokimachi, Naka-ku, Hiroshima-shi, Hiroshima	 	 	30	 	 	 	44,835	 
	Naoto Ikemura	 	1-11-17-101 Matsushima, Naha-shi, Okinawa	 	 	30	 	 	 	44,835	 
	Keisuke Kuno	 	2-10-1 Horinouchi, Hachioji-shi, Tokyo	 	 	25	 	 	 	37,362	 
	Hisashi Yamashiro	 	73-73-201 Aja, Naha-shi, Okinawa	 	 	15	 	 	 	22,417	 
	Jin Higa	 	473-1 Namizato, Motobu-cho, Kunigami-gun, Okinawa	 	 	10	 	 	 	14,945	 
	Toru Ohyama	 	2-47-23 Imajuku, Asahi-ku, Yokohama-shi, Kanagawa	 	 	10	 	 	 	14,945	 
	Gou Miyazaki	 	6-23-18-803 Sagamiono, Minami-ku, Sagamihara-shi, Kanagawa	 	 	5	 	 	 	7,472	 
	Masami Takasaki	 	2-1-4-404 Nakazato, Kita-ku, Tokyo	 	 	5	 	 	 	7,472	 
	Kou Shiba	 	1783-7 Kamiyugi, Hachioji-shi, Tokyo	 	 	1	 	 	 	1,494	 
	Naomi Sato	 	3-7-1-S2914, Shimomachi, Oomiya-ku, Saitama-Shi, Saitama	 	 	1	 	 	 	1,494	 
	Kaoru Yagasaki	 	1428-1-608, Takushi, Urasoe-shi, Okinawa	 	 	1	 	 	 	1,494	 
	Totals:	 	 	10,706	 	 	 	15,999,994	 

 

    	Exhibit A – Page 1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]